HomeTrialNCT06481306
🔬NCT06481306Phase 1Phase 2RECRUITING

A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease

Study Summary

The purpose of this study is to evaluate the safety and tolerability, pharmacokinetics and pharmacodynamics, pH and food effect, and preliminary efficacy of BMS-986470 in healthy volunteers and participants with sickle cell disease.

Interventions / Drugs
View on ClinicalTrials.gov ↗
Study Details
Enrollment184 participants
Primary Completion
Lead SponsorBristol-Myers Squibb
Data Retrieved2026-04-11 04:08:14.745465+00:00
Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.